IP Library Granted Patent US 6,844,433
Granted Patent B2
US 6,844,433 · App. 10/452,375 · Granted Jan 18, 2005

Nucleic acid labeling compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,844,433
App. No.
10/452,375
Granted
Jan 18, 2005
Kind
B2
Abstract

Nucleic acid labeling compounds containing heterocyclic derivatives are disclosed. The heterocyclic derivative containing compounds are synthesized by condensing a heterocyclic derivative with a cyclic group (e.g. a ribofuranose derivative). The labeling compounds are suitable for enzymatic attachment to a nucleic acid, either terminally or internally, to provide a mechanism of nucleic acid detection.

Claims (54)

1. A nucleic acid labeling compound of the following structure:

wherein A is H or a functional group that permits the attachment of the nucleic acid labeling compound to a nucleic acid;

X is O, S, NR 1 or CHR 2 , wherein R 1 and R 2 are, independently, H, alkyl or aryl;

Y is H, N 3 , F, OR 9 , SR 9 or NHR 9 , wherein R 9 is H, alkyl or aryl;

Z is H, N 3 , F or OR 10 , wherein R 10 is H, alkyl or aryl;

L is amino alkyl;

Q is a detectable moiety; and

M is a connecting group, wherein m is an integer ranging from 0 to about 3.

2. A nucleic acid labeling compound according to claim 1 , wherein A is H or H 4 O 9 P 3 —; X is O; Y is H or OR 9 , wherein R 9 is H, alkyl or aryl; Z is H, N 3 , F or OR 10 , wherein R 10 is H, alkyl or aryl; L is —NH(CH 2 ) n NH—, wherein n is an integer ranging from about 2 to about 10; Q is biotin or carboxyfluorescein; and M is —CO(CH 2 ) 5 NH— or —CO(CH 2 ) 5 NHCO(CH 2 ) 5 NH—, wherein m is 1 or 0.

3. A nucleic acid labeling compound according to claim 2 , wherein Y is H or OH; Z is H or OH; L is —NH(CH 2 ) 4 NH—; Q is biotin; and m is 0.

4. A nucleic acid labeling compound according to claim 2 , wherein Y is H or OH; Z is H or OH; L is —NH(CH 2 ) 4 NH—; Q is 5-carboxyfluorescein; and m is 0.

5. A nucleic acid labeling compound according to claim 2 , wherein A is H; Y is H; Z is H; L is —NH(CH 2 ) 4 NH—; Q is biotin; and m is 0.

6. A nucleic acid labeling compound according to claim 2 , wherein A is H 4 O 9 P 3 —; Y is H; Z is H; L is —NH(CH 2 ) 4 NH—; Q is biotin; and m is 0.

7. A nucleic acid labeling compound according to claim 2 , wherein A is H; Y is H; Z is H; L is —NH(CH 2 ) 4 NH—; Q is biotin; M is —CO(CH 2 ) 5 NH—; and m is 1.

8. A nucleic acid labeling compound according to claim 2 , wherein A is H 4 O 9 P 3 —; Y is H; Z is H; L is —NH(CH 2 ) 4 NH—; Q is biotin; M is —CO(CH 2 ) 5 NH—; and m is 1.

9. A nucleic acid labeling compound according to claim 1 , wherein A is H; Y is H; Z is H; L is —NH(CH 2 ) 4 NH—; Q is biotin; M is —CO(CH 2 ) 5 NH—; and m is 2.

10. A nucleic acid labeling compound according to claim 1 , wherein A is H 4 O 9 P 3 —; Y is H; Z is H; L is —NH(CH 2 ) 4 NH—; Q is biotin; M is —CO(CH 2 ) 5 NH—; and m is 2.

11. A nucleic acid labeling compound according to claim 2 , wherein A is H; Y is H; Z is H; L is —NH(CH 2 ) 4 NH—; Q is 5-carboxyfluorescein; and m is 0.

12. A nucleic acid labeling compound according to claim 2 , wherein A is H 4 O 9 P 3 —; Y is H; Z is H; L is —NH(CH 2 ) 4 NH—; Q is 5-carboxyfluorescein; and m is 0.

13. The nucleic acid labeling compound according to claim 6 , 8 , 10 or 12 having the formula:

wherein A, X, Y, Z, L, M, N, m and Q are as defined herein above.

14. The nucleic acid labeling compound according to claim 6 , 8 , 10 or 12 having the formula:

wherein A, X, Y, Z, L, M, N, m and Q are as defined herein above.

15. The nucleic acid labeling compound according to claim 6 , 8 , 10 or 12 having the formula:

wherein A, X, Y, Z, L, M, N, m and Q are as defined herein above.

16. A nucleic acid labeling compound of the following structure:

wherein A is H or a functional group that permits the attachment of the nucleic acid labeling compound to a nucleic acid;

X is O, S, NR 1 or CHR 2 , wherein R 1 and R 2 are, independently, H, alkyl or aryl;

Y is H, N 3 , F, OR 9 , SR 9 or NHR 9 , wherein R 9 is H, alkyl or aryl;

Z is H, N 3 , F or OR 10 , wherein R 10 is H, alkyl or aryl;

L is alkynyl alkyl;

Q is a detectable moiety; and

M is a connecting group, wherein m is an integer ranging from 0 to about 3.

17. A nucleic acid labeling compound according to claim 16 , wherein A is H or H 4 O 9 P 3 —; X is O; Y is H or OR 9 , wherein R 9 is H, alkyl or aryl; Z is H, N 3 , F or OR 10 , wherein R 10 is H, alkyl or aryl; L is —C≡CH 2 NH—; wherein n is an integer ranging from about 1 to about 10; Q is biotin or carboxyfluorescein; M is —CO(CH 2 ) 5 NH—; and m is 1 or 0.

18. A nucleic acid labeling compound according to claim 17 , wherein Y is H or OH; Z is H or OH; L is —C≡CH 2 NH—; Q is biotin; and m is 1.

19. A nucleic acid labeling compound according to claim 17 , wherein Y is H or OH; Z is H or OH; L is —C≡CH 2 NH—; Q is 5-carboxyfluorescein; and m is 1.

20. A nucleic acid labeling compound according to claim 17 , wherein A is H; Y is OH; Z is OH; L is —C≡CH 2 NH—; Q is biotin; M is —CO(CH 2 ) 5 NH—; and m is 1.

21. A nucleic acid labeling compound according to claim 17 , wherein A is H 4 O 9 P 3 —; Y is OH; Z is OH; L is —C≡CH 2 NH—; Q is biotin; M is —CO(CH 2 ) 5 NH—; and m is 1.

22. A nucleic acid labeling compound according to claim 17 , wherein A is H; Y is OH; Z is OH; L is —C≡CH 2 NH—; Q is 5-carboxyfluorescein; M is —CO(CH 2 ) 5 NH—; and m is 1.

23. A nucleic acid labeling compound according to claim 17 , wherein A is H 4 O 9 P 3 —; Y is OH; Z is OH; L is —C≡CH 2 NH—; Q is 5-carboxyfluorescein; M is —CO(CH 2 ) 5 NH—; and m is 1.

24. The nucleic acid labeling compound according to claim 21 or 23 having the formula:

wherein A, X, Y, Z, L, M, N, m and Q are as defined herein above.

25. The nucleic acid labeling compound according to claim 21 or 23 having the formula:

wherein A, X, Y, Z, L, M, N, m and Q are as defined herein above.

26. The nucleic acid labeling compound according to claim 21 or 23 having the formula:

wherein A, X, Y, Z, L, M, N, m and Q are as defined herein above.

27. A method of synthesizing a labeled nucleic acid comprising attaching a nucleic acid labeling compound according to claim 2 to a nucleic acid.

28. A method of synthesizing a labeled nucleic acid comprising attaching a nucleic acid labeling compound according to claim 13 to a nucleic acid.

29. A method of synthesizing a labeled nucleic acid comprising attaching a nucleic acid labeling compound according to claim 14 to a nucleic acid.

30. A method of synthesizing a labeled nucleic acid comprising attaching a nucleic acid labeling compound according to claim 15 to a nucleic acid.

31. A method of synthesizing a labeled nucleic acid comprising attaching a nucleic acid labeling compound according to claim 17 to a nucleic acid.

32. A method of synthesizing a labeled nucleic acid comprising attaching a nucleic acid labeling compound according to claim 24 to a nucleic acid.

33. A method of synthesizing a labeled nucleic acid comprising attaching a nucleic acid labeling compound according to claim 25 to a nucleic acid.

34. A method of synthesizing a labeled nucleic acid comprising attaching a nucleic acid labeling compound according to claim 26 to a nucleic acid.

Assignments (4)
NOTICE OF RELEASE Recorded Apr 5, 2016
From: BANK OF AMERICA, N.A.
To: AFFYMETRIX, INC.
Reel/Frame 038361/0891 →
RELEASE OF SECURITY INTEREST Recorded Nov 13, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
To: AFFYMETRIX, INC.
Reel/Frame 037109/0132 →
SECURITY INTEREST Recorded Oct 28, 2015
From: AFFYMETRIX, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 036988/0166 →
SECURITY AGREEMENT Recorded Jun 27, 2012
From: AFFYMETRIX, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 028465/0541 →